Simian Vaccine Evaluation Unit (SVEU)

猿猴疫苗评估中心 (SVEU)

• 批准号: 9121441
• 负责人: PHILLIP MARKHAM
• 金额: $ 18.22万
• 依托单位: ADVANCED BIOSCIENCE LABORATORIES, INC.
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-06-22 至 2013-06-22
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9121441
• 关键词: AIDS Vaccines; Advanced Development; Animals; Antibodies; Biological Assay; Caring; Cercocebus atys; Cercopithecine Herpesvirus 1; Cercopithecus pygerythrus; Chinese People; Contracts; Data; Databases; Development; Family suidae; Housing; Immunologics; Immunotherapy; In Vitro; Infection; Laboratories; Macaca; Macaca fascicularis; Macaca mulatta; Macaca nemestrina; Maintenance; Modality; National Institute of Allergy and Infectious Disease; Papio; Prevention; Protocols documentation; Records; Retroviridae; SIV; Tail; Testing; Tuberculosis; Type D Retrovirus; Virus; microbicide; nonhuman primate; protocol development; simian T cell lymphotrophic virus; vaccine evaluation

The scope and intent of the contracts for the Simian Vaccine Evaluation Units (SVEUs) is to enable the NIAID to use nonhuman primates to conduct studies that advance the development of effective AIDS vaccines, and to a less extent, the development of effective microbicides and other prevention modalities, and immune therapy.

猿猴疫苗评估单位 (SVEU) 合同的范围和目的是使 NIAID 能够利用非人类灵长类动物进行研究，推动有效艾滋病疫苗的开发，并在较小程度上促进有效杀微生物剂和其他药物的开发。预防方法和免疫治疗。